Dengue, chikungunya and zika virus coinfection: results of the national surveillance during the zika epidemic in Colombia.
Chikungunya Fever
/ epidemiology
Chikungunya virus
/ isolation & purification
Coinfection
/ epidemiology
Colombia
/ epidemiology
Dengue
/ epidemiology
Dengue Virus
/ isolation & purification
Epidemics
Epidemiological Monitoring
Zika Virus
/ isolation & purification
Zika Virus Infection
/ epidemiology
Coinfection
chikungunya
dengue
mortality
zika
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
28
3
2020
Statut:
ppublish
Résumé
Our objective was to determine the frequency of zika (ZIKV), chikungunya (CHIKV) and dengue (DENV) virus coinfection and describe the mortality cases that occurred during the epidemiologic surveillance of the ZIKV epidemic in Colombia. We analysed all cases of suspected ZIKV infection that were reported to the National Institute of Health (October 2015-December 2016). DENV, CHIKV and ZIKV RNA were detected in serum or tissue samples using polymerase chain reaction assay. Medical records of the fatal cases were reviewed. We identified that 23 871 samples were processed. The frequency of viral agents was 439 (1.84%) for DENV, 257 (1.07%) for CHIKV and 10118 (42.38%) for ZIKV. Thirty-four (0.14%) cases of coinfection were identified. The CHIKV-ZIKV coinfection was present in 28 cases (82.3%), DENV-CHIKV in three (8.8%) and DENV-ZIKV in three (8.8%). Seven (20.6%) coinfection cases were fatal (two DENV-CHIKV cases and five CHIKV-ZIKV cases). Two cases were foetal deaths and the others were related to neurological syndrome and sepsis. In conclusion, the frequency of arbovirus coinfection during epidemic of ZIKV was low, and CHIKV-ZIKV coinfection was the most common. Mortality was high among coinfection patients. The role of each virus in the mortality cases of coinfection warrants further studies.
Identifiants
pubmed: 30869010
pii: S095026881800359X
doi: 10.1017/S095026881800359X
pmc: PMC6518562
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e77Références
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Trans R Soc Trop Med Hyg. 1964 Jul;58:335-8
pubmed: 14175744
Presse Med. 2006 Nov;35(11 Pt 1):1656-1658
pubmed: 17086120
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Emerg Infect Dis. 2010 Mar;16(3):418-25
pubmed: 20202416
N Engl J Med. 2012 Apr 12;366(15):1423-32
pubmed: 22494122
Antiviral Res. 2013 Sep;99(3):345-70
pubmed: 23811281
World J Virol. 2012 Feb 12;1(1):11-22
pubmed: 24175207
Infect Genet Evol. 2015 Oct;35:134-41
pubmed: 26247719
BMJ. 2015 Sep 15;351:h4661
pubmed: 26374064
Emerg Infect Dis. 2015 Oct;21(10):1885-6
pubmed: 26401719
Euro Surveill. 2015;20(48):30079
pubmed: 26690898
BMC Infect Dis. 2016 Mar 03;16:84
pubmed: 26936191
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Medicine (Baltimore). 2016 Mar;95(12):e3201
pubmed: 27015222
Euro Surveill. 2016 Jun 2;21(22):
pubmed: 27277216
Clin Microbiol Rev. 2016 Jul;29(3):659-94
pubmed: 27281741
Clin Rheumatol. 2016 Oct;35(10):2381-5
pubmed: 27553387
Clin Infect Dis. 2016 Dec 15;63(12):1584-1590
pubmed: 27578819
Biomedica. 2015 Oct 26;36(0):35-43
pubmed: 27622791
N Engl J Med. 2016 Oct 20;375(16):1513-1523
pubmed: 27705091
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1409-1413
pubmed: 27977645
Lancet Infect Dis. 2017 Mar;17(3):e101-e106
pubmed: 28011234
Emerg Infect Dis. 2017 Jun;23(6):982-984
pubmed: 28296632
J Infect. 2017 Jun;74(6):611-615
pubmed: 28344113
N Engl J Med. 2017 Apr 20;376(16):1591-1593
pubmed: 28402236
Int J Infect Dis. 2018 Jul;72:25-27
pubmed: 29738826